Hologic Deal to Acquire Gen-Probe Passes US Antitrust Review | GenomeWeb

NEW YORK (GenomeWeb News) – Hologic today said that its $3.7 billion deal to acquire Gen-Probe has cleared US antitrust review.

The Bedford, Mass.-based firm said that the initial 30-day waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 had expired without a request for additional information from the US Federal Trade Commission.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Nature News explores the president's "science legacy."

In PLOS this week: genetic factors associated with facial features, a new mutation that makes individuals more prone to Brugada syndrome, and more.

Nutrigenomic companies offer gene-based diet advice, the Wall Street Journal reports.

Researchers have found a new kind of virus — one that starts out broken up into five parts.